Lyell Immunopharma, Inc. · NASDAQ:LYEL
Innovative Cellular Therapeutics Holdings Ltd reported a 9.80% stake in Lyell Immunopharma, Inc. (Schedule 13G)
Event Nov 6, 2025 · Filed Nov 13, 2025
Innovative Cellular Therapeutics Holdings Ltd reported a 9.80% stake in Lyell Immunopharma, Inc., 1,900,000 shares, as a passive investor on Nov 6, 2025. Filed Nov 13, 2025 (Schedule 13G).
- Stake
- 9.80%
- Shares
- 1,900,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Innovative Cellular Therapeutics Holdings Ltd | 9.80% | 1,900,000 |
Source
Related
- Lyell Immunopharma, Inc.
- Innovative Cellular Therapeutics Holdings Ltd
- Lyell Immunopharma, Inc. shareholders
- Schedule 13G/A · Innovative Cellular Therapeutics Holdings Ltd · Jun 18, 2026
- Form 4 · Aguirre Jarrad Mattieu · Oct 13, 2026
- Form 4 · Shook David · Sep 10, 2026
- Form 4 · Seely Lynn · Aug 25, 2026
- Form 4 · Hill Stephen J. · Aug 25, 2026
- Form 4 · Lee Gary K. · Aug 25, 2026